Hair-on-end skull induced by long-term G-CSF treatment in severe congenital neutropenia

被引:3
|
作者
Albert, Michael H.
Notheis, Gundula
Wintergerst, Uwe
Born, Christine
Schneider, Karl
机构
[1] Univ Munich, Dr Von Haunerschen Kinderspital, Dept Haematol Oncol, D-80337 Munich, Germany
[2] Univ Munich, Dr Von Haunerschen Kinderspital, Dept Infect Immun, D-80337 Munich, Germany
[3] Univ Munich, Klinikum Innenstadt, D-8000 Munich, Germany
[4] Univ Munich, Dr Von Haunerschen Kinderspital, Dept Pediat Radiol, D-80337 Munich, Germany
关键词
G-CSF; Marrow expansion; hair-on-end" skull; Kostmann syndrome; child;
D O I
10.1007/s00247-006-0363-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hair-on-end skull changes are typically seen in individuals suffering from thalassaemia. They are induced by widening of the diploic space due to marrow expansion that is a consequence of ineffective and excessive erythropoiesis. We present a child with severe congenital neutropenia who exhibited the typical hair-on-end sign on plain skull radiographs and MRI. In this patient the skull changes were very likely induced by the expansion of white blood cell precursors induced by long-term daily injections of recombinant human granulocyte colony stimulating factor (G-CSF) to treat his confounding disease. This case report is the first description of hair-on-end changes associated with the use of G-CSF.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [31] Outcomes of Pregnancies for Women with Severe Chronic Neutropenia with or without G-CSF Treatment
    Boxer, Laurence A.
    Bolyard, Audrey Anna
    Marrero, Tracy M.
    Alter, Blanche P.
    Bonilla, Mary Ann
    Link, Dan
    Newburger, Peter E.
    Rosenberg, Philip S.
    Shimamura, Akiko
    Dale, David C.
    BLOOD, 2010, 116 (21) : 635 - 636
  • [32] Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment
    Ward, AC
    van Aesch, YM
    Gits, J
    Schelen, AM
    de Koning, JP
    van Leeuwen, D
    Freedman, MH
    Touw, IP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04): : 497 - 507
  • [33] G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms
    Donini, Marta
    Fontana, Stefania
    Savoldi, Gianfranco
    Vermi, William
    Tassone, Laura
    Gentili, Francesca
    Zenaro, Elena
    Ferrari, Daniela
    Notarangelo, Lucia D.
    Porta, Fulvio
    Facchetti, Fabio
    Notarangelo, Luigi D.
    Dusi, Stefano
    Badolato, Raffaele
    BLOOD, 2007, 109 (11) : 4716 - 4723
  • [34] RAS and G-CSF receptor mutations are mutually exclusive in leukemogenesis in severe congenital neutropenia.
    Germeshausen, M
    Kratz, C
    Ballmaier, M
    Shannon, KM
    Welte, K
    BLOOD, 2005, 106 (11) : 860A - 860A
  • [35] Deletional mutation in the external domain of the G-CSF receptor in a child with G-CSF-resistant severe congenital neutropenia.
    Sinha, S
    Douglass, K
    Bhatnagar, N
    Corey, SJ
    BLOOD, 2000, 96 (11) : 610A - +
  • [36] Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
    Ward, AC
    van Aesch, YM
    de Koning, JP
    Schelen, AM
    Smith, L
    Freedman, MH
    Touw, IP
    BLOOD, 1998, 92 (10) : 206A - 206A
  • [37] A patient with severe congenital neutropenia, with point mutations in the cytoplasmic domain of the G-CSF receptor mRNA, express a normal G-CSF receptor protein.
    Kasper, B
    Hadam, MR
    Pilz, C
    Germeshausen, M
    Tidow, N
    Welte, K
    BLOOD, 1996, 88 (10) : 3260 - 3260
  • [38] Severe Neutropenia In Children After Renal Transplantation: Incidence, Course And Treatment With G-csf
    Becker-cohen, Rachel
    Rinat, Choni
    Ben-shalom, Efiat
    Feinstein, Sofia
    Geylis, Michael
    Frishberg, Yaacov
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1777 - 1777
  • [39] Long-term Outcome of Filgrastim (G-CSF) in ALS Patients
    Johannesen, Siw
    Bruun, Tim-Henrik
    Budeus, Bettina
    Peters, Sebastian
    Meyer, Anne-Louise
    Kobor, Ines
    Hsam, Ohnmar
    Wirth, Anna-Maria
    Schulte-Mattler, Wilhelm
    Klatt, Sabine
    Bogdahn, Ulrich
    NEUROLOGY, 2018, 90
  • [40] LONG-TERM ADMINISTRATION OF G-CSF IN THE MYELODYSPLASTIC SYNDROMES (MDS)
    YOSHIDA, Y
    UCHINO, H
    MAEKAWA, T
    NOMURA, T
    MIZOGUCHI, H
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 920 - 920